HUP9700274A3 - Optically active (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)-piperazin-1-yl]-phenoxy}-butiric acid as inhibitor of celle-adhesion, preparation and use of this compound, pharmaceutical composition containing this compound - Google Patents

Optically active (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)-piperazin-1-yl]-phenoxy}-butiric acid as inhibitor of celle-adhesion, preparation and use of this compound, pharmaceutical composition containing this compound

Info

Publication number
HUP9700274A3
HUP9700274A3 HU9700274A HUP9700274A HUP9700274A3 HU P9700274 A3 HUP9700274 A3 HU P9700274A3 HU 9700274 A HU9700274 A HU 9700274A HU P9700274 A HUP9700274 A HU P9700274A HU P9700274 A3 HUP9700274 A3 HU P9700274A3
Authority
HU
Hungary
Prior art keywords
compound
celle
piperazin
phenoxy
pyridyl
Prior art date
Application number
HU9700274A
Other languages
Hungarian (hu)
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of HU9700274D0 publication Critical patent/HU9700274D0/en
Publication of HUP9700274A2 publication Critical patent/HUP9700274A2/en
Publication of HUP9700274A3 publication Critical patent/HUP9700274A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
HU9700274A 1995-06-01 1996-05-28 Optically active (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)-piperazin-1-yl]-phenoxy}-butiric acid as inhibitor of celle-adhesion, preparation and use of this compound, pharmaceutical composition containing this compound HUP9700274A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative

Publications (3)

Publication Number Publication Date
HU9700274D0 HU9700274D0 (en) 1997-04-28
HUP9700274A2 HUP9700274A2 (en) 1999-06-28
HUP9700274A3 true HUP9700274A3 (en) 2000-02-28

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700274A HUP9700274A3 (en) 1995-06-01 1996-05-28 Optically active (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)-piperazin-1-yl]-phenoxy}-butiric acid as inhibitor of celle-adhesion, preparation and use of this compound, pharmaceutical composition containing this compound

Country Status (31)

Country Link
EP (1) EP0796247A1 (en)
JP (1) JP2885941B2 (en)
KR (1) KR100245957B1 (en)
AT (1) AT406675B (en)
AU (1) AU710105B2 (en)
BE (1) BE1009520A5 (en)
BR (1) BR9606409A (en)
CA (1) CA2194397A1 (en)
CH (1) CH691808A5 (en)
CZ (1) CZ26997A3 (en)
DE (1) DE19680509T1 (en)
DK (1) DK10697A (en)
ES (1) ES2137886B1 (en)
FI (1) FI970393A (en)
GB (1) GB2304340B (en)
GR (1) GR1002702B (en)
HU (1) HUP9700274A3 (en)
IE (1) IE960405A1 (en)
IL (1) IL118477A0 (en)
IT (1) IT1290839B1 (en)
LU (1) LU90008B1 (en)
MC (1) MC2418A1 (en)
MX (1) MX9700379A (en)
NL (1) NL1003243C2 (en)
NO (1) NO307460B1 (en)
NZ (1) NZ308597A (en)
PL (1) PL318440A1 (en)
SE (1) SE510812C2 (en)
SK (1) SK13097A3 (en)
TR (1) TR199700020T1 (en)
WO (1) WO1996038416A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
GB9406143D0 (en) * 1993-03-29 1994-05-18 Zeneca Ltd Heterocyclic derivatives
CA2155307A1 (en) * 1993-03-29 1994-10-13 Michael Garth Wayne Heterocyclic compounds as platelet aggregation inhibitors

Also Published As

Publication number Publication date
AT406675B (en) 2000-07-25
EP0796247A1 (en) 1997-09-24
WO1996038416A1 (en) 1996-12-05
GB9627127D0 (en) 1997-02-19
BE1009520A5 (en) 1997-04-01
ATA900596A (en) 1999-12-15
CZ26997A3 (en) 1997-08-13
SK13097A3 (en) 1997-08-06
NO970437D0 (en) 1997-01-31
NO307460B1 (en) 2000-04-10
FI970393A0 (en) 1997-01-30
JP2885941B2 (en) 1999-04-26
GR1002702B (en) 1997-05-22
CH691808A5 (en) 2001-10-31
TR199700020T1 (en) 1997-04-22
KR970704689A (en) 1997-09-06
MX9700379A (en) 1997-04-30
BR9606409A (en) 1997-09-30
PL318440A1 (en) 1997-06-09
GB2304340B (en) 1998-07-29
CA2194397A1 (en) 1996-12-05
IL118477A0 (en) 1996-09-12
IE960405A1 (en) 1996-12-11
ES2137886B1 (en) 2000-08-16
KR100245957B1 (en) 2000-04-01
LU90008B1 (en) 1997-04-16
DE19680509T1 (en) 1997-12-04
SE510812C2 (en) 1999-06-28
DK10697A (en) 1997-04-01
SE9700203L (en) 1997-01-24
FI970393A (en) 1997-01-30
ITMI961113A1 (en) 1997-12-01
SE9700203D0 (en) 1997-01-24
GB2304340A (en) 1997-03-19
ES2137886A1 (en) 1999-12-16
NZ308597A (en) 1998-11-25
AU710105B2 (en) 1999-09-16
ITMI961113A0 (en) 1996-05-31
NO970437L (en) 1997-02-20
NL1003243C2 (en) 1996-12-04
MC2418A1 (en) 1997-05-23
JPH09512836A (en) 1997-12-22
AU5827296A (en) 1996-12-18
HUP9700274A2 (en) 1999-06-28
HU9700274D0 (en) 1997-04-28
IT1290839B1 (en) 1998-12-14

Similar Documents

Publication Publication Date Title
IL116325A (en) Substituted 4-(1,2,3,4-tetrahydro-1-naphthalenyl)-1h-imidazoles and substituted 4-(2,3-dihydro-1h-inden-1-yl)-1h-imidazoles the optically active isomers thereof and racemic mixtures thereof their preparation and pharmaceutical compositions containing them
EP1452172A3 (en) Multiple unit pharmaceutical preparation
HUP0201275A2 (en) Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts and pharmaceutical composition containing the compound
EP0433842A3 (en) 1,2,3-triazole derivatives active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them
HUP9603237A3 (en) Crystalline hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxydo-3-oxo-2,3-dihydro-benzisothiazo-2-yl)-butyl]-amino-methyl}-chromane, process for the preparation thereof and pharmaceutical compositions containing them
HUP0102250A3 (en) Compounds of unstable dipeptidyl peptidase iv inhibitors, pharmaceutical compositions comprising thereof and their use
AU1912197A (en) New inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them
NO963499L (en) Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
FI973279A (en) Novel farnesyltransferase inhibitors, their preparation and pharmaceutical compositions containing them
IL143858A (en) 4-(aminomethyl)-piperidine benzamides, process for their preparation and pharmaceutical compositions containing them
GB8827390D0 (en) Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
ATE332894T1 (en) A PYRIDINE-N-OXIDE DERIVATIVE AND A PROCESS FOR ITS IMPLEMENTATION INTO PHARMACEUTICAL ACTIVE INGREDIENTS
HUP0000960A3 (en) Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
AU3176695A (en) Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid
UA41978C2 (en) N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidine-1-yl)-ethyl]-2,2-diphenylacetamide hydrochloride, a PROCESS for the preparation thereof and a pharmaceutical composition
IL120984A (en) Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl) phenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl)acetylamino)-3-phenylpropionate, their preparation and pharmaceutical compositions containing them
HUP9700274A3 (en) Optically active (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)-piperazin-1-yl]-phenoxy}-butiric acid as inhibitor of celle-adhesion, preparation and use of this compound, pharmaceutical composition containing this compound
HUP0400889A3 (en) Processes for the preparation of (r)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol and pharmaceutical compositions containing the compound
HUP9902316A3 (en) 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists and pharmaceutical compositions containing them
HUP9900401A3 (en) Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases, pharmaceutical compositions containing them and their use
EE200100219A (en) Esters of (+) - alpha (2,3-dimethoxyphenyl) -1- [2- (4-fluorophenyl) ethyl] -4-piperidinemethanol, process for their preparation, use and pharmaceutical composition
IL112604A (en) Derivatives of (2-(ar) alkyldithio indane-2-carboxamido) tricyclic-oxobenzazepine-carboxylic acid and similar compounds useful as inhibitors of enkephalinase and ace, their preparation and pharmaceutical compositions containing them
GB9610093D0 (en) (-)-(3R)-methyl-4-[4-[4-(4-pyridyl) piperazin-1-yl] phenoxy] butyric acid
ZA964509B (en) (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyric acid
FR2734818B1 (en) (-) - (3R) -3-METHYL-4- {4- [4- (4-PYRIDYL) PIPERAZINE-1-YL- PHENOXY} -BUTYRIC ACID, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME